IAM
INFI

Iridian Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Iridian Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,350
Closed -$159K – 125
2014
Q1 		$159K Buy
+13,350
New +$179K ﹤0.01% 122

Other funds holding INFI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Iridian Asset Management's INFI Position: Q2 2014 in Review

Iridian Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2014, closing a stake of 13,350 shares — an estimated $159K sold.

Iridian Asset Management first reported a position in INFI in Q1 2014 and held it in 1 quarter. The position peaked at $159K in Q1 2014. 98 funds tracked by Wall St. Rank hold INFI as of Q2 2014.

  • Iridian Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Iridian Asset Management sold 13,350 Infinity Pharmaceuticals, Inc. shares in Q2 2014, an estimated $159K.
  • Iridian Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 1 quarter.
  • Iridian Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $159K in Q1 2014.
  • 98 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2014.

Based on Iridian Asset Management's 13F filing for Q2 2014, filed 11 Aug 2014.